Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 462

1.

Bile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents.

Christiansen CB, Trammell SAJ, Wewer Albrechtsen NJ, Schoonjans K, Albrechtsen R, Gillum MP, Kuhre RE, Holst JJ.

Am J Physiol Gastrointest Liver Physiol. 2019 Feb 15. doi: 10.1152/ajpgi.00010.2019. [Epub ahead of print]

PMID:
30767682
2.

Postprandial Nutrient Handling and Gastrointestinal Secretion of Hormones After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.

Svane MS, Bojsen-Møller KN, Martinussen C, Dirksen C, Madsen JL, Reitelseder S, Holm L, Rehfeld JF, Kristiansen VB, van Hall G, Holst JJ, Madsbad S.

Gastroenterology. 2019 Feb 8. pii: S0016-5085(19)30363-4. doi: 10.1053/j.gastro.2019.01.262. [Epub ahead of print]

PMID:
30742833
3.

Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.

Bergmann NC, Lund A, Gasbjerg LS, Meessen ECE, Andersen MM, Bergmann S, Hartmann B, Holst JJ, Jessen L, Christensen MB, Vilsbøll T, Knop FK.

Diabetologia. 2019 Jan 25. doi: 10.1007/s00125-018-4810-0. [Epub ahead of print]

PMID:
30683945
4.

Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysis.

Broberg B, Madsen JL, Fuglsang S, Holst JJ, Christensen KB, Rydahl C, Idorn T, Feldt-Rasmussen B, Hornum M.

Neurogastroenterol Motil. 2019 Jan 22:e13554. doi: 10.1111/nmo.13554. [Epub ahead of print]

PMID:
30667131
5.

Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study.

Steineck IIK, Ranjan A, Schmidt S, Clausen TR, Holst JJ, Nørgaard K.

Diabetologia. 2019 Jan 14. doi: 10.1007/s00125-018-4807-8. [Epub ahead of print]

PMID:
30643924
6.

Separate and Combined Gluco-Metabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 in Healthy Individuals.

Gasbjerg LS, Helsted MM, Hartmann B, Jensen MH, Gabe MBN, Sparre-Ulrich AH, Veedfald S, Stensen S, Lanng AR, Bergmann NC, Christensen MB, Vilsbøll T, Holst JJ, Rosenkilde MM, Knop FK.

Diabetes. 2019 Jan 9. pii: db181123. doi: 10.2337/db18-1123. [Epub ahead of print]

PMID:
30626611
7.

Mechanisms Preserving Insulin Action during High Dietary Fat Intake.

Lundsgaard AM, Holm JB, Sjøberg KA, Bojsen-Møller KN, Myrmel LS, Fjære E, Jensen BAH, Nicolaisen TS, Hingst JR, Hansen SL, Doll S, Geyer PE, Deshmukh AS, Holst JJ, Madsen L, Kristiansen K, Wojtaszewski JFP, Richter EA, Kiens B.

Cell Metab. 2019 Jan 8;29(1):229. doi: 10.1016/j.cmet.2018.10.002. No abstract available.

PMID:
30625306
8.

Mechanisms of action of a carbohydrate-reduced, high-protein diet in reducing the risk of postprandial hypoglycemia after Roux-en-Y gastric bypass surgery.

Kandel D, Bojsen-Møller KN, Svane MS, Samkani A, Astrup A, Holst JJ, Madsbad S, Krarup T.

Am J Clin Nutr. 2019 Jan 9. doi: 10.1093/ajcn/nqy310. [Epub ahead of print]

PMID:
30624666
9.

Effects of active commuting and leisure-time exercise on appetite in individuals with overweight and obesity.

Quist JS, Blond MB, Gram AS, Steenholt CB, Janus C, Holst JJ, Rehfeld JF, Sjödin A, Stallknecht B, Rosenkilde M.

J Appl Physiol (1985). 2019 Jan 3. doi: 10.1152/japplphysiol.00239.2018. [Epub ahead of print]

PMID:
30605397
10.

High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine.

Larsen JR, Svensson CK, Vedtofte L, Jakobsen ML, Jespersen HS, Jakobsen MI, Koyuncu K, Schjerning O, Nielsen J, Ekstrøm CT, Holst JJ, Correll CU, Vilsbøll T, Fink-Jensen A.

CNS Spectr. 2018 Dec 31:1-12. doi: 10.1017/S1092852918001311. [Epub ahead of print]

PMID:
30596361
11.

The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial.

Samkani A, Skytte MJ, Anholm C, Astrup A, Deacon CF, Holst JJ, Madsbad S, Boston R, Krarup T, Haugaard SB.

Lipids Health Dis. 2018 Dec 27;17(1):295. doi: 10.1186/s12944-018-0953-8.

12.

Biliopancreatic diversion with duodenal switch (BPD-DS) and single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) result in distinct post-prandial hormone profiles.

Pereira SS, Guimarães M, Almeida R, Pereira AM, Lobato CB, Hartmann B, Hilsted L, Holst JJ, Nora M, Monteiro MP.

Int J Obes (Lond). 2018 Dec 11. doi: 10.1038/s41366-018-0282-z. [Epub ahead of print]

PMID:
30538284
13.

Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery.

Wewer Albrechtsen NJ, Geyer PE, Doll S, Treit PV, Bojsen-Møller KN, Martinussen C, Jørgensen NB, Torekov SS, Meier F, Niu L, Santos A, Keilhauer EC, Holst JJ, Madsbad S, Mann M.

Cell Syst. 2018 Dec 26;7(6):601-612.e3. doi: 10.1016/j.cels.2018.10.012. Epub 2018 Dec 5.

14.

Energy intake, gastrointestinal transit, and gut hormone release in response to oral triglycerides and fatty acids in men with and without severe obesity.

Dirksen C, Graff J, Fuglsang S, Rehfeld JF, Holst JJ, Madsen JL.

Am J Physiol Gastrointest Liver Physiol. 2019 Mar 1;316(3):G332-G337. doi: 10.1152/ajpgi.00310.2018. Epub 2018 Dec 6.

15.

Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.

Bahne E, Sun EWL, Young RL, Hansen M, Sonne DP, Hansen JS, Rohde U, Liou AP, Jackson ML, de Fontgalland D, Rabbitt P, Hollington P, Sposato L, Due S, Wattchow DA, Rehfeld JF, Holst JJ, Keating DJ, Vilsbøll T, Knop FK.

JCI Insight. 2018 Dec 6;3(23). pii: 93936. doi: 10.1172/jci.insight.93936. [Epub ahead of print]

16.

Glucose homeostasis in statin users-The LIFESTAT study.

Morville T, Dohlmann T, Kuhlman AB, Monberg T, Torp M, Hartmann B, Holst JJ, Larsen S, Helge JW, Dela F.

Diabetes Metab Res Rev. 2018 Dec 5:e3110. doi: 10.1002/dmrr.3110. [Epub ahead of print]

PMID:
30517978
17.

The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormones.

Rudenko O, Shang J, Munk A, Ekberg JP, Petersen N, Engelstoft MS, Egerod KL, Hjorth SA, Wu M, Feng Y, Zhou YP, Mokrosinski J, Thams P, Reimann F, Gribble F, Rehfeld JF, Holst JJ, Treebak JT, Howard AD, Schwartz TW.

Mol Metab. 2019 Jan;19:49-64. doi: 10.1016/j.molmet.2018.10.012. Epub 2018 Nov 5.

18.

Abscisic acid stimulates the release of insulin and of GLP-1 in the rat perfused pancreas and intestine.

Booz V, Christiansen CB, Kuhre RE, Saltiel MY, Sociali G, Schaltenberg N, Fischer AW, Heeren J, Zocchi E, Holst JJ, Bruzzone S.

Diabetes Metab Res Rev. 2019 Feb;35(2):e3102. doi: 10.1002/dmrr.3102. Epub 2018 Dec 13.

PMID:
30468287
19.

Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs.

Rehfeld JF, Knop FK, Asmar A, Madsbad S, Holst JJ, Asmar M.

Scand J Gastroenterol. 2018 Dec;53(12):1429-1432. doi: 10.1080/00365521.2018.1530297. Epub 2018 Nov 19.

PMID:
30449207
20.

Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects.

Demant M, Bagger JI, Suppli MP, Lund A, Gyldenløve M, Hansen KB, Hare KJ, Christensen M, Sonne DP, Holst JJ, Vilsbøll T, Knop FK.

Metab Syndr Relat Disord. 2018 Dec;16(10):530-536. doi: 10.1089/met.2018.0066. Epub 2018 Oct 16.

PMID:
30325692

Supplemental Content

Loading ...
Support Center